Sign Up to like & get
recommendations!
1
Published in 2020 at "Journal of Clinical Pharmacology"
DOI: 10.1002/jcph.1788
Abstract: Although people living with human immunodeficiency virus and other comorbidities are expected to experience more grievous consequences with corona virus disease 2019 (COVID‐19), recent cohort studies did not indicate this. Antiretrovirals (ARVs) might have a…
read more here.
Keywords:
antiretrovirals prophylaxis;
review;
role;
sars cov ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "3 Biotech"
DOI: 10.1007/s13205-020-02554-1
Abstract: The new viral pandemic of COVID-19 is caused by a novel coronavirus (SARS-CoV-2) that has brought the world at another unprecedented crisis in terms of health and economy. The lack of specific therapeutics necessitates other…
read more here.
Keywords:
better nothing;
probiotics prophylaxis;
covid something;
respiratory ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Indian Heart Journal"
DOI: 10.1016/j.ihj.2020.11.005
Abstract: Background HCQ is a commonly recommended drug for the prophylaxis of COVID-19. One of its rare side-effect includes QTc prolongation. Methods This was a prospective, cross sectional and observational study conducted on Hydroxychloroquine (HCQ) among…
read more here.
Keywords:
qtc prolongation;
hcq prophylaxis;
healthcare workers;
prophylaxis covid ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph15091068
Abstract: Due to the rapid, vast, and emerging global spread of the Coronavirus Disease 2019 (COVID-19) pandemic, many drugs were quickly repurposed in a desperate attempt to unveil a miracle drug. Ivermectin (IVM), an antiparasitic macrocyclic…
read more here.
Keywords:
prophylaxis covid;
antiparasitic agent;
covid;
treatment prophylaxis ... See more keywords